Cobolimab Uses, Dosage, Side Effects and more
Cobolimab is under investigation in clinical trial NCT04655976 (Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants).
| Trade Name | Cobolimab |
| Generic | Cobolimab |
| Cobolimab Other Names | Cobolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
